Evidence map›Paper›PMID 24038145›Full record

ArticleJournal of applied toxicology : JAT2014

Effects of butyltins on mitogen-activated-protein kinase kinase kinase and Ras activity in human natural killer cells.

Lindsay J Celada, Margaret M Whalen

Abstract read
In one paragraph

Article in Journal of applied toxicology : JAT, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Lindsay J CeladaDepartment of Biological Sciences, Tennessee State University, Nashville, TN, USA.
Margaret M Whalen
Tennessee State University · US

Funding

TRAININGU54CA163066 · NCI · TENNESSEE STATE UNIVERSITY · PI MARGARET M WHALEN · 2011 to 2026
$12.8M
NCI NIH HHS 1U54CA163066-02NCI NIH HHS U54 CA163066
6 · The paper itself

Abstract

Butyltins (BTs) contaminate the environment and are found in human blood. BTs, tributyltin (TBT) and dibutyltin (DBT) diminish the cytotoxic function and levels of key proteins of human natural killer (NK) cells. NK cells are an initial immune defense against tumors, virally infected cells and antibody-coated cells and thus critical to human health. The signaling pathways that regulate NK cell functions include mitogen-activated protein kinases (MAPKs). Studies have shown that exposure to BTs leads to activation of specific MAPKs and MAPK kinases (MAP2Ks) in human NK cells. MAP2K kinases (MAP3Ks) are upstream activators of MAP2Ks, which then activate MAPKs. The current study examined if BT-induced activation of MAP3Ks was responsible for MAP2K and thus, MAPK activation. This study examines the effects of TBT and DBT on the total levels of two MAP3Ks, c-Raf and ASK1, as well as activating and inhibitory phosphorylation sites on these MAP3Ks. In addition, the immediate upstream activator of c-Raf, Ras, was examined for BT-induced alterations. Our results show significant activation of the MAP3K, c-Raf, in human NK cells within 10 min of TBT exposure and the MAP3K, ASK1, after 1 h exposures to TBT. In addition, our results suggest that both TBT and DBT affect the regulation of c-Raf.

Indexed as

Dose-Response Relationship, DrugGene Expression RegulationHumansKiller Cells, NaturalMAP Kinase Kinase Kinase 5Mitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesOrganotin CompoundsPhosphorylationProto-Oncogene Proteins c-rafProto-Oncogene Proteins p21(ras)Signal TransductionTrialkyltin Compoundsdi-n-butyltinMAP3K5 protein, humanMAP Kinase Kinase Kinase 5Mitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesOrganotin CompoundsProto-Oncogene Proteins c-rafProto-Oncogene Proteins p21(ras)Trialkyltin CompoundstributyltinASK1butyltinc-Raf (Raf1)MAPK/ERK PathwayNatural Killer cellsRas

Identifiers

PMID24038145
PMCPMC3868639
OpenAlexW1510759393

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.